FDA Drug Application (202096) for MONTELUKAST SODIUM by AUROBINDO PHARMA LTD

Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Application Number202096
Product Number001
FormTABLET, CHEWABLE;ORAL
DosageEQ 4MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMONTELUKAST SODIUM
Active IngredientMONTELUKAST SODIUM

Active IngredientCount
List of drugs with Active Ingredient MONTELUKAST SODIUM2


Back to FDA Applications sponsored by AUROBINDO PHARMA LTD